WASHINGTON — CRN on Monday sent the following letter to U.S. Senator Dick Durbin (D-Ill.) in response to him introducing the Dietary Supplement Listing Act of 2024.
CRN sends letter to Sen. Durbin regarding reintroduction of Dietary Supplement Listing Act
Related
FDA approves Glenmark’s generic Flonase nasal spray
Fluticasone propionate is a corticosteroid used to treat nasal allergy symptoms, including congestion, sneezing, and a runny nose.
Rael gains TowerBrook backing for expansion
The investment will support Rael’s retail expansion, product innovation and global growth.
Yellow Wood Partners to acquire Nestlé's Holistic Health platform
$1.0 billion acquisition comprises VMS leading brands, including Nature's Bounty, the No. 2 VMS brand, and select specialty brands.
Health supports and braces: 2026 and beyond
Technological advancements, improved materials, and variations in support methods are trends that will shape the category for years to come.
Latest
Independent Pharmacy Cooperative acquires USave Pharmacy Group
The deal brings together two organizations with a shared commitment to preserving and strengthening independent community pharmacy.
FDA approves Glenmark’s generic Flonase nasal spray
Fluticasone propionate is a corticosteroid used to treat nasal allergy symptoms, including congestion, sneezing, and a runny nose.
Rael gains TowerBrook backing for expansion
The investment will support Rael’s retail expansion, product innovation and global growth.
Yellow Wood Partners to acquire Nestlé's Holistic Health platform
$1.0 billion acquisition comprises VMS leading brands, including Nature's Bounty, the No. 2 VMS brand, and select specialty brands.